A detailed history of Alpha Omega Wealth Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Alpha Omega Wealth Management LLC holds 48,836 shares of GILD stock, worth $4.29 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
48,836
Previous 49,279 0.9%
Holding current value
$4.29 Million
Previous $3.38 Million 21.06%
% of portfolio
0.75%
Previous 0.65%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$66.59 - $83.99 $29,499 - $37,207
-443 Reduced 0.9%
48,836 $4.09 Million
Q2 2024

Jul 25, 2024

BUY
$63.15 - $72.88 $102,871 - $118,721
1,629 Added 3.42%
49,279 $3.38 Million
Q1 2024

Apr 17, 2024

SELL
$71.58 - $87.29 $44,809 - $54,643
-626 Reduced 1.3%
47,650 $3.49 Million
Q4 2023

Jan 30, 2024

SELL
$73.27 - $83.09 $10,990 - $12,463
-150 Reduced 0.31%
48,276 $3.91 Million
Q3 2023

Oct 11, 2023

SELL
$73.94 - $80.67 $22,329 - $24,362
-302 Reduced 0.62%
48,426 $3.63 Million
Q2 2023

Jul 28, 2023

SELL
$76.01 - $86.7 $182,043 - $207,646
-2,395 Reduced 4.68%
48,728 $3.76 Million
Q1 2023

Apr 19, 2023

SELL
$77.31 - $88.08 $258,447 - $294,451
-3,343 Reduced 6.14%
51,123 $4.24 Million
Q4 2022

Feb 01, 2023

SELL
$62.32 - $89.47 $677,667 - $972,896
-10,874 Reduced 16.64%
54,466 $4.68 Million
Q3 2022

Oct 18, 2022

SELL
$59.54 - $68.01 $57,277 - $65,425
-962 Reduced 1.45%
65,340 $4.03 Million
Q2 2022

Jul 21, 2022

BUY
$57.72 - $65.01 $178,239 - $200,750
3,088 Added 4.88%
66,302 $4.1 Million
Q1 2022

Apr 29, 2022

BUY
$57.92 - $72.58 $644,070 - $807,089
11,120 Added 21.35%
63,214 $3.76 Million
Q4 2021

Jan 18, 2022

BUY
$64.88 - $73.64 $48,724 - $55,303
751 Added 1.46%
52,094 $3.75 Million
Q3 2021

Oct 13, 2021

BUY
$67.69 - $73.03 $110,131 - $118,819
1,627 Added 3.27%
51,343 $3.59 Million
Q2 2021

Jul 01, 2021

BUY
$63.47 - $69.35 $214,592 - $234,472
3,381 Added 7.3%
49,716 $3.42 Million
Q1 2021

Apr 29, 2021

BUY
$60.0 - $68.46 $144,960 - $165,399
2,416 Added 5.5%
46,335 $3 Million
Q4 2020

Feb 05, 2021

BUY
$56.65 - $64.55 $147,516 - $168,088
2,604 Added 6.3%
43,919 $2.56 Million
Q3 2020

Nov 05, 2020

BUY
$62.1 - $78.08 $4,347 - $5,465
70 Added 0.17%
41,315 $2.61 Million
Q2 2020

Jul 27, 2020

SELL
$72.34 - $84.0 $831,910 - $966,000
-11,500 Reduced 21.8%
41,245 $3.17 Million
Q1 2020

May 04, 2020

SELL
$62.63 - $80.22 $85,239 - $109,179
-1,361 Reduced 2.52%
52,745 $3.94 Million
Q4 2019

Feb 05, 2020

BUY
$61.62 - $67.78 $77,456 - $85,199
1,257 Added 2.38%
54,106 $3.52 Million
Q3 2019

Nov 12, 2019

BUY
$62.51 - $69.0 $229,599 - $253,437
3,673 Added 7.47%
52,849 $3.46 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $30,192 - $33,857
488 Added 1.0%
49,176 $3.32 Million
Q1 2019

May 02, 2019

BUY
$62.53 - $70.05 $1.29 Million - $1.44 Million
20,576 Added 73.19%
48,688 $3.17 Million
Q4 2018

Jan 18, 2019

SELL
$60.54 - $79.0 $1.24 Million - $1.62 Million
-20,493 Reduced 42.16%
28,112 $1.76 Million
Q3 2018

Nov 01, 2018

BUY
$71.28 - $78.92 $45,975 - $50,903
645 Added 1.34%
48,605 $3.75 Million
Q2 2018

Aug 14, 2018

BUY
$64.88 - $75.68 $49,762 - $58,046
767 Added 1.63%
47,960 $3.4 Million
Q1 2018

May 01, 2018

BUY
$72.84 - $88.8 $140,508 - $171,295
1,929 Added 4.26%
47,193 $3.56 Million
Q4 2017

Feb 06, 2018

BUY
$71.15 - $83.52 $206,121 - $241,957
2,897 Added 6.84%
45,264 $3.24 Million
Q3 2017

Nov 03, 2017

BUY
$72.11 - $85.47 $40,453 - $47,948
561 Added 1.34%
42,367 $3.43 Million
Q2 2017

Aug 07, 2017

BUY
N/A
41,806
41,806 $2.96 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Alpha Omega Wealth Management LLC Portfolio

Follow Alpha Omega Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Omega Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Omega Wealth Management LLC with notifications on news.